Inhibrx Biosciences Inc (INBX)
14.93
-0.52
(-3.37%)
USD |
NASDAQ |
Nov 14, 12:46
Inhibrx Biosciences Shareholders Equity (Quarterly): 219.37M for June 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 219.37M |
| Date | Value |
|---|---|
| March 31, 2024 | -10.77M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-10.77M
Minimum
Mar 2024
219.37M
Maximum
Jun 2024
104.30M
Average
104.30M
Median
Shareholders Equity (Quarterly) Benchmarks
| CEL-SCI Corp | 8.473M |
| AIM ImmunoTech Inc | 6.102M |
| IGC Pharma Inc | 7.88M |
| NovaBay Pharmaceuticals Inc | -0.617M |
| Protalix BioTherapeutics Inc | 28.58M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 258.42M |
| Total Liabilities (Quarterly) | 39.05M |
| Current Ratio | 6.198 |